REGENERON PHARMACEUTICALS, INC. Restricted Cash and Cash Equivalents, Noncurrent
REGENERON PHARMACEUTICALS, INC. (REGN) had Restricted Cash and Cash Equivalents, Noncurrent of $3.40 million as of 2010-09-30, per its 10-Q filed 2010-10-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Investments, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2010-10-28
- 2010-09-30: Restricted Cash and Cash Equivalents, Noncurrent $3.40M.
- 2010-06-30: Restricted Cash and Cash Equivalents, Noncurrent $3.40M.
- 2009-12-31: Restricted Cash and Cash Equivalents, Noncurrent $1.60M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2010-09-30 | $3.40M 10-Q · filed 2010-10-28 |
| 2010-06-30 | $3.40M 10-Q · filed 2010-07-28 |
| 2009-12-31 | $1.60M 10-Q · filed 2010-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |